| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.034 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |